Regulating Homeopathic Products - A Century of Dilute Interest

Scott H Podolsky; Aaron S Kesselheim

doi:10.1056/NEJMp1513393

Regulating Homeopathic Products - A Century of Dilute Interest

N Engl J Med. 2016 Jan 21;374(3):201-3. doi: 10.1056/NEJMp1513393.

Authors

Scott H Podolsky¹, Aaron S Kesselheim

Affiliation

¹ From the Department of Global Health and Social Medicine, Harvard Medical School (S.H.P.), and the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - both in Boston.

PMID: 26789866
DOI: 10.1056/NEJMp1513393

Abstract

In 2015, U.S. government agencies began considering greater regulation of both homeopathic drugs and the advertising of such products. These actions came after more than a century of missed opportunities to regulate homeopathic medicines.

Publication types

Historical Article

MeSH terms

Government Regulation / history
History, 19th Century
History, 20th Century
History, 21st Century
Homeopathy / history*
Legislation, Drug / history*
Materia Medica / history*
Materia Medica / standards
United States
United States Food and Drug Administration / history

Substances

Materia Medica